Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure
Open Access
- 19 January 2015
- journal article
- Published by Taylor & Francis in Biomarkers
- Vol. 20 (2) , 123-131
Abstract
The stability of circulating miRNAs, their non-invasive sampling techniques and deregulation in diseases make them potential candidate biomarkers of biological effect. Here, we profiled the level of 84 plasma miRNAs in 30 smokers, 20 non-smokers and 20 ex-smokers. A robust statistical strategy was applied with replicate samples to account for reproducibility of the results. We identified differential expression of miR-124 and let-7a between the smoking and control groups. We further explored the dose-response relationship of miR-124 and let-7a with two biomarkers of tobacco exposure and found that this relationship was affected by adjustments based on age, pack-year and gender.Keywords
This publication has 45 references indexed in Scilit:
- MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinomaMolecular Cancer, 2014
- miRNAs in Breast Cancer: Ready for Real Time?Pharmacogenomics, 2012
- Circulating MicroRNAsCirculation Research, 2012
- let‐7 and miR‐17‐92: Small‐sized major players in lung cancer developmentCancer Science, 2010
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)Methods, 2010
- The MicroRNA miR-124 Promotes Neuronal Differentiation by Triggering Brain-Specific Alternative Pre-mRNA SplicingMolecular Cell, 2007
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- Molecular epidemiology of lung cancerAnnals of Oncology, 1999